When Cara Buono first started playing Karen Wheeler in Netflix’s Stranger Things, her daughter was just 3 years old. While Karen was raising Nancy, Mike, and later, Holly, in the fictional, demogorgon ...

Cara Delevingne is ready to part ways with her New York City home. The 33-year-old model has placed her historic home in Gramercy Park on the market for $9.9 million with listing broker Stefani Berkin ...

Cara Delevingne discounted her massive Manhattan home by more than $1 million this week, according to a StreetEasy listing update. The English model-actress purchased the Gramercy Park triplex from ...

Stranger Things‘ Cara Buono addressed the show recasting — and aging up — her onscreen daughter ahead of the show’s fifth and final season. “In season 1, Holly is four years old and she’s in Joyce’s ...

Cara Cara Fall 2025 ready-to-wear runway, fashion show & collection photos at New York Fashion Week, February 2025.

Esteemed photographer Cara Romero–wife–and esteemed potter and printmaker Diego Romero–husband–share an exhibition at the Crocker Art Museum in Sacramento. ByChadd Scott, Contributor. Forbes ...

Known for her ever-evolving style (and iconic bushy eyebrows circa 2013, ofc), Cara Delevingne is no stranger to a transformative beauty look; from many a micro fringe to vanilla crême hues, it's safe ...

There are only iconic hairstyles in this building. Cara Delevingne debuted her new hair transformation at the 2025 Cannes Film Festival May 21, proving that dark gothic locks will always be timeless.

Cara Delevingne, it would seem, is in her goth era. The star, who is no stranger to pushing the boundaries when it comes to hairstyles (remember her pink pixie haircut or her mohawk era?), unveiled a ...

Grammy-winning singer Alessia Cara has made her long-awaited return to the spotlight after taking some time away from making music. The Canadian crooner’s fourth studio album Love & Hyperbole is out ...

Pruritus drug developer Cara Therapeutics kicked off the year halving its headcount, and the biotech has now found a new home via a merger with fibrosis disease-focused Tvardi Therapeutics. The merger ...